Evoke Pharma Inc

CIK 1403708 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Evoke Pharma Inc.

Recent SEC filings

FiledFormAccession number
Dec 30, 202515-12G0001193125-25-336315
Dec 19, 2025SCHEDULE 13D/A0001104659-25-123157
Dec 19, 202540001104659-25-123156
Dec 18, 2025EFFECT9999999995-25-003821
Dec 18, 2025EFFECT9999999995-25-003819
Dec 18, 2025EFFECT9999999995-25-003824
Dec 18, 2025EFFECT9999999995-25-003825
Dec 18, 2025EFFECT9999999995-25-003817
Dec 18, 2025EFFECT9999999995-25-003818
Dec 17, 2025S-8 POS0001193125-25-322699
Dec 17, 202540001193125-25-322637
Dec 17, 2025POS AM0001193125-25-322658
Dec 17, 2025POS AM0001193125-25-322662
Dec 17, 202540001193125-25-322643
Dec 17, 202540001193125-25-322644
Dec 17, 202540001193125-25-322639
Dec 17, 2025S-8 POS0001193125-25-322718
Dec 17, 202525-NSE0001354457-25-001278
Dec 17, 20258-K0001193125-25-321801
Dec 17, 2025S-8 POS0001193125-25-322724
Dec 17, 2025POS AM0001193125-25-322685
Dec 17, 2025SC 14D9/A0001193125-25-321812
Dec 17, 2025POS AM0001193125-25-322667
Dec 17, 2025POS AM0001193125-25-322647
Dec 17, 2025S-8 POS0001193125-25-322729